ArticleEuropean journal of human genetics : EJHG2009
Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing.
Article in European journal of human genetics : EJHG, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Pregnant couples' attitude toward extended pre-conceptional genomic screening.Croatian medical journal · 2024Article
- Genetic/genomic testing: defining the parameters for ethical, legal and social implications (ELSI).BMC medical ethics · 2021Article
- Confidentiality and data sharing: vulnerabilities of the Mexican Genomics Sovereignty Act.Journal of community genetics · 2015Article
- The challenge of implementing genetic tests with clinical utility while avoiding unsound applications.Journal of community genetics · 2014Article
- The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes.European journal of human genetics : EJHG · 2013Review
- Communication about DTC testing: commentary on a 'family experience of personal genomics'.Journal of genetic counseling · 2012Article
- Genetic testing legislation in Western Europe-a fluctuating regulatory target.Journal of community genetics · 2012Article
- Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.BMC medical ethics · 2011Review
- Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.European journal of human genetics : EJHG · 2011Review
- Personal genetics: regulatory framework in Europe from a service provider's perspective.European journal of human genetics : EJHG · 2011Review
- Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.European journal of human genetics : EJHG · 2010Article
- Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned.Genome medicine · 2010Article
- Only connect: personal genomics and the future of American medicine.Molecular diagnosis & therapy · 2010Article
- Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?Human genetics · 2010Article
- Direct to consumer genetic tests.European journal of human genetics : EJHG · 2009Article
- Challenges of incorporating pharmacogenomics into clinical practice.Gastrointestinal cancer research : GCR · 2009Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of tests for genetic susceptibility to common complex diseases has raised concerns. These concerns relate to evaluation of the scientific and clinical validity and utility of the tests, quality assurance of laboratories and testing services, advice and protection for the consumer and the appropriate regulatory and policy response. How these concerns are interpreted and addressed is an ongoing debate. If the possibility of using the discoveries from genomic science to improve health is to be realised without losing public confidence, then improvements in the evaluation and mechanisms for control of supply of tests may be as important as the science itself.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.